Mysterious oligomerization of the amyloidogenic proteins
about
Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsMisfolding and amyloid aggregation of apomyoglobinStructural and oxygen binding properties of dimeric horse myoglobinModulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanismsHuman apolipoprotein A-I-derived amyloid: its association with atherosclerosisβ2-Microglobulin amyloid fibril-induced membrane disruption is enhanced by endosomal lipids and acidic pHDynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.The model of amyloid aggregation of Escherichia coli RNA polymerase σ70 subunit based on AFM data and in vitro assays.High-resolution conformation and backbone dynamics of a soluble aggregate of apomyoglobin119.Effects of several quinones on insulin aggregation.The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change modelA strategy for synthesis of pathogenic human immunoglobulin free light chains in E. coli.Glycation accelerates fibrillization of the amyloidogenic W7FW14F apomyoglobinProgressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy.Probing fibril dissolution of the repeat domain of a functional amyloid, Pmel17, on the microscopic and residue levelThe Toxic Effects of Pathogenic Ataxin-3 Variants in a Yeast Cellular ModelSupramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation.Detection of high-molecular-weight amyloid serum protein complexes using biological on-line tracer sedimentation.Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington's disease.On-surface aggregation of α-synuclein at nanomolar concentrations results in two distinct growth mechanismsPrefoldin protects neuronal cells from polyglutamine toxicity by preventing aggregation formation1,5-Diazacyclooctanes, as Exclusive Oxidative Polyamine Metabolites, Inhibit Amyloid-β(1-40) FibrillizationRole of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation.Computational approaches to understanding protein aggregation in neurodegeneration.Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose.Mechanisms of amyloid fibril formation--focus on domain-swapping.A deadly spread: cellular mechanisms of α-synuclein transfer.Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases.Intrinsically disordered proteins and novel strategies for drug discovery.Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.α-Synuclein oligomers: an amyloid pore? Insights into mechanisms of α-synuclein oligomer-lipid interactions.Amyloid toxicity and platelet-activating factor signaling.Advances in electrochemical detection for study of neurodegenerative disorders.The route to protein aggregate superstructures: Particulates and amyloid-like spherulites.Evidence of a prion-like transmission of p53 amyloid in Saccharomyces cerevisiae.A Novel In Vitro CypD-Mediated p53 Aggregation Assay Suggests a Model for Mitochondrial Permeability Transition by Chaperone Systems.Application and use of differential scanning calorimetry in studies of thermal fluctuation associated with amyloid fibril formation.β2-microglobulin amyloid fibrils are nanoparticles that disrupt lysosomal membrane protein trafficking and inhibit protein degradation by lysosomesHuman cystatin C monomer, dimer, oligomer, and amyloid structures are related to health and disease.
P2860
Q26822552-98DBF8AB-75C9-4DF4-A6D4-74E15F762918Q26830356-AAFE0485-A73B-4D8D-96D4-14B781762CA7Q27681956-667242EC-58A0-43A5-AB3A-2E972454000EQ28259424-08E1CC32-7955-40C0-AB71-92FD7FF7B6C3Q28479210-773C422D-8300-4D4A-A927-FADEA34522C4Q28541669-FEABCA82-3F92-4D9D-AA74-FE9F9469B97AQ30523072-D6C7398A-65E8-4E6C-8D0D-420C3B4B0F1EQ30585591-E9C37D9E-9D41-4219-A1AE-F51861985007Q33808009-7ABF2EE2-FD98-46DE-AED8-53CA0500B8BEQ33876973-F0B53745-3528-4911-B222-49C35BCCC0A0Q34087988-B24E247D-736C-40DF-8099-8B7F2DE16198Q35006134-5BB5C1DE-7853-41A0-809F-5E464AE1B906Q35063787-E731A04C-7326-4282-AF3D-984632DF23AEQ35577123-1745278D-4CC3-43C8-BDFF-ECA1D2DE8C8BQ35597175-2D4CF7E3-A3B9-4693-8924-C2A9B72B45FDQ35656171-9660F016-7ABC-4ADF-9809-61C94F9EF22AQ35810050-2B642F34-F1D1-41F1-8E48-670CF0DDE95DQ35966921-10A8C8FE-9499-451B-80DE-EF056BF295B0Q36148314-884E59BA-0B55-4B0D-BB07-B6BDD6F95209Q36309073-54D7B2C7-39C5-4D61-A08E-A8DE254C0275Q36709104-F42329BD-1B29-4A8C-A98E-9BFCAE505BF0Q37000637-6703C6A9-65DD-4EF4-B81C-36F4F0E8EEB6Q37394657-00582D55-59AC-4BD7-9901-6A50045194B2Q37587111-E338FA9F-21D2-4A86-90BB-92E27D5DFBE9Q37715960-846C2590-8CDF-41E7-B101-EBF78B9490B5Q37807985-8B736323-956F-455C-9870-77DF0DC39FE3Q37871074-AE142229-8572-4138-81A7-AE17CFF1BF29Q37874930-169346DF-BF0E-4431-A30A-ECDC6C5B3619Q37922607-86B63B06-36C8-4808-A523-3908C2981C8BQ38007557-156B5198-D734-404B-924A-B9732483C6E1Q38021865-12EBCE72-DD16-4B86-BBEF-68EA6FDAFC5FQ38041484-2641A9D8-469E-4CAA-A318-5BAB2F5695BDQ38061367-A869DEC1-62EB-4C50-A97B-0E9233772921Q38093077-4DEECA22-D057-4060-B849-E83CCF565997Q38548820-F838D9E5-EE2D-4527-A5A7-A865A0C4EE85Q38718360-A38DBD3F-C2EB-43B5-A961-8AED0D796198Q38752375-F795FBE5-770A-4BCD-966F-E7FDCE734E51Q38783081-F5ED70BC-9F38-4A8C-9C73-7C6E1A36C667Q38942020-DA3F92C2-42F2-4E3A-B00B-B07212154A5DQ38987127-DB523EF3-E6C8-4881-8EB9-87CD385B29FC
P2860
Mysterious oligomerization of the amyloidogenic proteins
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mysterious oligomerization of the amyloidogenic proteins
@ast
Mysterious oligomerization of the amyloidogenic proteins
@en
Mysterious oligomerization of the amyloidogenic proteins
@nl
type
label
Mysterious oligomerization of the amyloidogenic proteins
@ast
Mysterious oligomerization of the amyloidogenic proteins
@en
Mysterious oligomerization of the amyloidogenic proteins
@nl
prefLabel
Mysterious oligomerization of the amyloidogenic proteins
@ast
Mysterious oligomerization of the amyloidogenic proteins
@en
Mysterious oligomerization of the amyloidogenic proteins
@nl
P2860
P1433
P1476
Mysterious oligomerization of the amyloidogenic proteins
@en
P2860
P304
P356
10.1111/J.1742-4658.2010.07721.X
P407
P577
2010-06-10T00:00:00Z